National and Kapodistrian University of Athens
Ανάπτυξη φορέων τύπου spuma που εκφράζουν anti-α-σφαιρίνης short hairpin RNA (shRNA): μελέτη της δράσης τους in vitro σε καλλιέργειες ερυθροκυτταρικών σειρών και αρχέγονων αιμοποιητικών κυττάρων
Abstract
dc:descriptionAim of the present study was the development of foamy virus (FV) vectors for efficient and stable RNAi, and their deployment in gene therapy approaches for beta-thalassemia. Initially, by using GFP as a target gene, we examined the efficiency of FV vectors harbouring the mouse U6 (mU6) and human Hl RNA Pol III promoters in different human cell lines and mouse hematopoietic stem cells (HSC) and showed that both vector types mediated very efficient gene silencing, with as low as one vector copy per cell. We also examined the difference in the silencing efficiency of the two promoters, as well as the impact of the expression system and cellular context in the evaluation of the overall RNAi effects. The efficiency of the HI vectors was further shown by the successful silencing of BCR-ABL oncogene, whereas mU6 vectors also induced efficient and stable gene silencing in vivo, following bone marrow transplantation. In the context of beta-thalassemia, we designed and cloned candidate shRNAs targeting the mouse and human alpha-globin, for the down-regulation of its expression and the amelioration of the alpha-chain imbalance, which is the main pathophysiological feature of the disease. Initial experiments performed in vitro using mouse MEL and human K562 cells, identified at least two shRNAs for each species, capable of efficient and sustained downregulation, even at low MOI (1-5). Ex vivo, functional studies using HSCs of both mouse and human origin, confirmed the efficiency of all candidate shRNA sequences in down-regulating a-globin by 50 to 10% and indicated that a-globin silencing can induce an erythroid differentiation that assimilates the aberrant erythropoiesis in thalassemic syndromes. In ex vivo experiments with HSCs from β-thalassemic mice, this FV-RNAi induced “alpha-thalassemia” was accompanied by the restoration of a balanced context of erythropoiesis, as depicted by the normalisation of BFU-E numbers and the expression of erythroid markers. Collectively, the present study supports the dynamic of the FV-RNAi system in the efficient and functional down-regulation of excess alpha-globin, further supporting its clinical validity as a therapeutic target for β-thalassemia.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Παπαδάκη, Μαγδαληνή
- Papadaki, Magdalini
Subjects
dc:subject × 17- Αιμοσφαιρίνη
- Θαλασσαιμικά σύνδρομα
- Γονιδιακή θεραπεία
- Σύγχρονες μοριακές θεραπείες
- Β-μεσογειακή αναιμία
- Κυτταροκαλλιέργειες
- Ανάλυση νουκλεϊκών οξέων
- Ανάλυση γονιδιακής έκφρασης
- Κυτταρομετρία ροής
- Πειράματα in vivo
- Αφοϊικοί φορείς
- Α-σφαιρίνη
- RNAi
- Φυσικές Επιστήμες
- Βιολογία
- Natural Sciences
- Biological Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/34940